Stay updated on Fianlimab Combo vs Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Fianlimab Combo vs Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fianlimab Combo vs Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    A new revision entry (v3.6.5) was added to the history and the prior entry (v3.6.4) was removed, indicating an update to the record's revision history.
    Difference
    0.1%
    Check dated 2026-08-08T23:31:28.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    The study history now includes revision v3.6.4, replacing the previous v3.6.3. This indicates a small update to the record metadata rather than substantive content changes.
    Difference
    0.1%
    Check dated 2026-07-25T17:38:37.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    A new Study Status entry was added on 2026-07-06 (with a related date marker 2026-07-01 and index 32). An older entry dated 2025-05-13 was removed.
    Difference
    0.3%
    Check dated 2026-07-11T14:14:03.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    Revision: v3.6.3 is now listed as the latest revision in the study history, replacing v3.6.2. This indicates a minor update to the page’s revision tracking rather than changes to core study content.
    Difference
    0.1%
    Check dated 2026-07-04T08:08:39.000Z thumbnail image
  8. Check
    59 days ago
    Change Detected
    Summary
    The history now includes a new Revision: v3.6.2 entry, replacing v3.6.0, indicating a newer build label applied to the page.
    Difference
    0.1%
    Check dated 2026-06-27T04:14:29.000Z thumbnail image
  9. Check
    73 days ago
    Change Detected
    Summary
    The study's history shows the recruitment status changed to no longer looking for participants, signaling that enrollment has ended. The record version advanced to v3.6.0, superseding the previous v3.5.5 entry.
    Difference
    0.3%
    Check dated 2026-06-12T20:23:05.000Z thumbnail image

Stay in the know with updates to Fianlimab Combo vs Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fianlimab Combo vs Pembrolizumab in Melanoma Clinical Trial page.